FI115826B - Terapeuttinen aine rasva-aineenvaihdunnan häiriöön - Google Patents

Terapeuttinen aine rasva-aineenvaihdunnan häiriöön Download PDF

Info

Publication number
FI115826B
FI115826B FI963312A FI963312A FI115826B FI 115826 B FI115826 B FI 115826B FI 963312 A FI963312 A FI 963312A FI 963312 A FI963312 A FI 963312A FI 115826 B FI115826 B FI 115826B
Authority
FI
Finland
Prior art keywords
tcf
therapeutic agent
cholesterol
disorder
serum
Prior art date
Application number
FI963312A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963312A (fi
FI963312A0 (fi
Inventor
Hiroaki Masunaga
Kanji Higashio
Akira Shiota
Nobuaki Fujise
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI963312A publication Critical patent/FI963312A/fi
Publication of FI963312A0 publication Critical patent/FI963312A0/fi
Application granted granted Critical
Publication of FI115826B publication Critical patent/FI115826B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
FI963312A 1994-12-27 1996-08-26 Terapeuttinen aine rasva-aineenvaihdunnan häiriöön FI115826B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP33788494 1994-12-27
JP6337884A JPH08176007A (ja) 1994-12-27 1994-12-27 脂質代謝異常治療剤
JP9502707 1995-12-27
PCT/JP1995/002707 WO1996020004A1 (en) 1994-12-27 1995-12-27 Therapeutic agent for disorder of lipid metabolism

Publications (3)

Publication Number Publication Date
FI963312A FI963312A (fi) 1996-08-26
FI963312A0 FI963312A0 (fi) 1996-08-26
FI115826B true FI115826B (fi) 2005-07-29

Family

ID=18312906

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963312A FI115826B (fi) 1994-12-27 1996-08-26 Terapeuttinen aine rasva-aineenvaihdunnan häiriöön

Country Status (16)

Country Link
EP (1) EP0754051B1 (xx)
JP (1) JPH08176007A (xx)
KR (1) KR100395695B1 (xx)
AT (1) ATE247975T1 (xx)
AU (1) AU710513B2 (xx)
CA (1) CA2184248A1 (xx)
DE (1) DE69531608T2 (xx)
DK (1) DK0754051T3 (xx)
ES (1) ES2201128T3 (xx)
FI (1) FI115826B (xx)
HU (1) HU220139B (xx)
NO (1) NO318099B1 (xx)
NZ (1) NZ298141A (xx)
TW (1) TW480173B (xx)
WO (1) WO1996020004A1 (xx)
ZA (1) ZA9510981B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
WO1998041230A1 (fr) * 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent preventif et/ou curatif de la cachexie
KR100568664B1 (ko) * 1997-03-14 2006-06-13 다이이치세이야꾸 가부시끼가이샤 악액질 예방 및/또는 치료제
US6498019B1 (en) 1997-04-11 2002-12-24 Takeda Chemical Industries, Ltd. Lecithin-cholesterol acyltransferase protein
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
ES2276409T3 (es) * 1992-07-16 2007-06-16 Daiichi Pharmaceutical Co., Ltd. Composicion medica que contiene tcf-ii.

Also Published As

Publication number Publication date
NZ298141A (en) 2000-12-22
TW480173B (en) 2002-03-21
JPH08176007A (ja) 1996-07-09
NO318099B1 (no) 2005-01-31
HU220139B (hu) 2001-11-28
FI963312A (fi) 1996-08-26
EP0754051A1 (en) 1997-01-22
KR100395695B1 (ko) 2004-02-14
DK0754051T3 (da) 2003-09-29
WO1996020004A1 (en) 1996-07-04
DE69531608D1 (de) 2003-10-02
ATE247975T1 (de) 2003-09-15
NO963551L (no) 1996-10-25
HUT76085A (en) 1997-06-30
ZA9510981B (en) 1996-07-17
ES2201128T3 (es) 2004-03-16
AU710513B2 (en) 1999-09-23
KR970701058A (ko) 1997-03-17
FI963312A0 (fi) 1996-08-26
HU9602341D0 (en) 1996-10-28
EP0754051B1 (en) 2003-08-27
CA2184248A1 (en) 1996-07-04
NO963551D0 (no) 1996-08-26
DE69531608T2 (de) 2004-02-19
AU4355096A (en) 1996-07-19

Similar Documents

Publication Publication Date Title
Turley et al. Cholesterol-lowering action of psyllium mucilloid in the hamster: sites and possible mechanisms of action
Guarnieri et al. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis
Vatassery et al. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats
US4703062A (en) Parenteral nutrition with medium and long chain triglycerides
JPH09512552A (ja) 腎疾患および不全の治療方法ならびに組成物
EP0321128A1 (en) Fatty acid compositions
FI115826B (fi) Terapeuttinen aine rasva-aineenvaihdunnan häiriöön
KR19990076920A (ko) L-카르노신을 함유하는 신부전증 치료용 조성물
KR100696417B1 (ko) 진세노사이드 Ｒｂ₁을 함유하는 뇌혈관 재생ㆍ재구축 촉진제 및 신경조직 이차변성 억제제
US5021239A (en) Use of M-CSF to improve lipoprotein cholesterol profiles
CA1242974A (en) Parenteral nutrition with medium and long chain triglycerides
CA2100720C (en) Medicinal composition comprising tcf-ii
Brousseau Emerging role of high-density lipoprotein in the prevention of cardiovascular disease
Ney et al. Alteration in lipoprotein composition with intravenous compared to intragastric fat-free feeding in the rat
Foss et al. Lipoatrophy produced in mice and rabbits by a fraction prepared from the urine from patients with congenital generalized lipodystrophy
Warner et al. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
EP0459377A2 (en) Use of E1 prostaglandin to cure male erectile inpotence
Salako et al. The effects of porcine calcitonin on renal function in the rabbit
MXPA02000912A (es) Uso de l-carnitina y sus derivados alcanoilo para la preparacion de un medicamento util para el tratamiento de pacientes que sufren nefropatias diabeticas o por insuficiencia metabolica.
JP2006160757A (ja) 脂質代謝異常治療剤
WO1994027629A1 (en) Method to control appetite and treat obesity
KR0156623B1 (ko) 상피세포 손상 치료용 조성물
Ishida et al. The protective effects of SA3443, a novel cyclic disulfide, on chronic liver injuries in rats
Mulroney et al. Suppression of growth hormone release restores phosphaturic response to PTH in immature rats
KR20220108543A (ko) 페노피브레이트를 유효성분으로 포함하는 체내 콜레스테롤 배출 조절에 의한골관절염 예방 또는 치료용 약제학적 조성물

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115826

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: ATLAS PHARMACEUTICALS INC.

Free format text: ATLAS PHARMACEUTICALS INC.